Search details
1.
Simvastatin in Critically Ill Patients with Covid-19.
N Engl J Med
; 389(25): 2341-2354, 2023 12 21.
Article
in English
| MEDLINE | ID: mdl-37888913
2.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Article
in English
| MEDLINE | ID: mdl-36566761
3.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med
; 384(16): 1491-1502, 2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33631065
4.
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
Ann Neurol
; 94(3): 547-560, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37245090
5.
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development.
Ann Neurol
; 91(2): 165-175, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34935174
6.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA
; 329(1): 39-51, 2023 01 03.
Article
in English
| MEDLINE | ID: mdl-36525245
7.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA
; 329(14): 1183-1196, 2023 04 11.
Article
in English
| MEDLINE | ID: mdl-37039790
8.
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
JAMA
; 330(18): 1745-1759, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37877585
9.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet
; 398(10303): 843-855, 2021 09 04.
Article
in English
| MEDLINE | ID: mdl-34388395
10.
Hypothermia for Patients Requiring Evacuation of Subdural Hematoma: A Multicenter Randomized Clinical Trial.
Neurocrit Care
; 36(2): 560-572, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34518968
11.
How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.
JAMA
; 327(1): 67-74, 2022 01 04.
Article
in English
| MEDLINE | ID: mdl-34982138
12.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(13): 1247-1259, 2022 04 05.
Article
in English
| MEDLINE | ID: mdl-35315874
13.
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 326(17): 1690-1702, 2021 Nov 02.
Article
in English
| MEDLINE | ID: mdl-34606578
14.
Conditional Power: How Likely Is Trial Success?
JAMA
; 329(6): 508-509, 2023 02 14.
Article
in English
| MEDLINE | ID: mdl-36689237
15.
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
J Infect
; 88(4): 106130, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38431155
16.
African American men and women's attitude toward mental illness, perceptions of stigma, and preferred coping behaviors.
Nurs Res
; 62(3): 185-94, 2013.
Article
in English
| MEDLINE | ID: mdl-23328705
17.
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial.
Br J Gen Pract
; 72(720): e446-e455, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35440469
18.
Analyzing Repeated Measurements Using Mixed Models.
JAMA
; 315(4): 407-8, 2016 Jan 26.
Article
in English
| MEDLINE | ID: mdl-26813213
19.
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet Respir Med
; 9(9): 1010-1020, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34329624
20.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Intensive Care Med
; 47(8): 867-886, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34251506